Aapo L. Aro

4.7k total citations · 1 hit paper
101 papers, 3.1k citations indexed

About

Aapo L. Aro is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Aapo L. Aro has authored 101 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Aapo L. Aro's work include Cardiac electrophysiology and arrhythmias (50 papers), Atrial Fibrillation Management and Outcomes (35 papers) and Cardiac Arrhythmias and Treatments (34 papers). Aapo L. Aro is often cited by papers focused on Cardiac electrophysiology and arrhythmias (50 papers), Atrial Fibrillation Management and Outcomes (35 papers) and Cardiac Arrhythmias and Treatments (34 papers). Aapo L. Aro collaborates with scholars based in Finland, United States and Sweden. Aapo L. Aro's co-authors include Heikki V. Huikuri, Juhani Junttila, Harri Rissanen, Jani T. Tikkanen, Olli Anttonen, Tuomas Kerola, Antti Reunanen, Georg Alfthan, Iris Erlund and Sumeet S. Chugh and has published in prestigious journals such as New England Journal of Medicine, Circulation and Stroke.

In The Last Decade

Aapo L. Aro

95 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Outcome Associated with Early Repolarization on Electrocardiography

2009 533 citations Jani T. Tikkanen, Olli Anttonen et al. profile →

Peers

Countries citing papers authored by Aapo L. Aro

Since Specialization

Citations

This map shows the geographic impact of Aapo L. Aro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aapo L. Aro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aapo L. Aro more than expected).

Fields of papers citing papers by Aapo L. Aro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aapo L. Aro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aapo L. Aro. The network helps show where Aapo L. Aro may publish in the future.

Co-authorship network of co-authors of Aapo L. Aro

This figure shows the co-authorship network connecting the top 25 collaborators of Aapo L. Aro. A scholar is included among the top collaborators of Aapo L. Aro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aapo L. Aro. Aapo L. Aro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reduced dose direct oral anticoagulants and time-in-therapeutic-range defined warfarin in new-onset atrial fibrillation: a report from the nationwide FinACAF study 2025 ·European Heart Journal Open ·(unknown), Mika Lehto, Olli Halminen, (unknown), Mikko Niemi, Konsta Teppo, (unknown), Jari Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Aapo L. Aro, Juha Hartikainen, Gregory Y.H. Lip, Juhani Airaksinen	0
2	Factors associated with oral anticoagulant non-use at first ischemic stroke in atrial fibrillation: A nationwide study 2025 ·European Stroke Journal ·(unknown), Aapo L. Aro, Olli Halminen, (unknown), Miika Linna, (unknown), Konsta Teppo, Pirjo Mustonen, Jari Haukka, Juha Hartikainen, Juhani Airaksinen, Mika Lehto, Jukka Putaala	0
3	Sex- and age-specific differences in the use of antiarrhythmic therapies among atrial fibrillation patients: a nationwide cohort study 2024 ·EP Europace ·Birgitta Salmela, Jussi Jaakkola, (unknown), J Inkovaara, Aapo L. Aro, Konsta Teppo, (unknown), Olli Halminen, Jari Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Juha Hartikainen, Juhani Airaksinen, Mika Lehto	3
4	Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study 2024 ·Annals of Medicine ·Mika Lehto, (unknown), Olli Halminen, Jari Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Janne Kinnunen, (unknown), Konsta Teppo, (unknown), (unknown), (unknown), Mikko Niemi, Aapo L. Aro, Juha Hartikainen, Juhani Airaksinen, (unknown)	3
5	Temporal trends in mortality and causes of death in patients with incident atrial fibrillation: a nationwide register study from 2010 to 2018 2024 ·BMJ Open ·(unknown), Birgitta Salmela, Aapo L. Aro, Olli Halminen, Konsta Teppo, Jari Haukka, Jukka Putaala, (unknown), Pirjo Mustonen, Juha Hartikainen, Juhani Airaksinen, Mika Lehto	4
6	Thromboembolic and bleeding complications after elective cardioversion of atrial fibrillation: a nationwide cohort study 2024 ·EP Europace ·(unknown), Mika Lehto, Olli Halminen, Jukka Putaala, Jari Haukka, (unknown), Konsta Teppo, Pirjo Mustonen, Miika Linna, Juha Hartikainen, Juhani Airaksinen, Aapo L. Aro	2
7	Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications 2024 ·European Heart Journal ·Konsta Teppo, Juhani Airaksinen, Jussi Jaakkola, Olli Halminen, Birgitta Salmela, (unknown), Jari Haukka, Jukka Putaala, Miika Linna, Aapo L. Aro, Pirjo Mustonen, Juha Hartikainen, Gregory Y.H. Lip, Mika Lehto	31
8	Aortic Stenosis and Outcomes in Patients With Atrial Fibrillation: A Nationwide Cohort Study 2023 ·Journal of the American Heart Association ·Konsta Teppo, Juhani Airaksinen, Fausto Biancari, Jussi Jaakkola, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, (unknown), Juha Hartikainen, Aapo L. Aro, Mika Lehto	3
9	Trans-oesophageal echocardiography-guided implantation of a cardiac resynchronization therapy pacemaker and successful ablation of the atrioventricular node after TriClip: case report 2023 ·European Heart Journal - Case Reports ·Suvi Tuohinen, Aapo L. Aro, Jarkko Karvonen	3
10	Temporal trends of gender disparities in oral anticoagulant use in patients with atrial fibrillation 2023 ·European Journal of Clinical Investigation ·Konsta Teppo, Juhani Airaksinen, Jussi Jaakkola, Olli Halminen, Birgitta Salmela, (unknown), (unknown), Jari Haukka, Jukka Putaala, Miika Linna, Aapo L. Aro, Pirjo Mustonen, Juha Hartikainen, Mika Lehto	15
11	Ischemic Stroke Temporally Associated With New-Onset Atrial Fibrillation: A Population-Based Registry-Linkage Study 2023 ·Stroke ·Jukka Putaala, Konsta Teppo, Olli Halminen, Jari Haukka, (unknown), Jussi Jaakkola, (unknown), Miika Linna, Pirjo Mustonen, Janne Kinnunen, Tuomas Kiviniemi, Aapo L. Aro, Juha Hartikainen, Juhani Airaksinen, Mika Lehto, (unknown)	8
12	Stroke in Patients with Atrial Fibrillation: Epidemiology, Screening, and Prognosis 2023 ·Journal of Clinical Medicine ·(unknown), Nicolas Martinez‐Majander, (unknown), (unknown), Aapo L. Aro, Sami Curtze, Sami Pakarinen, Mika Lehto, Jukka Putaala	3
13	Trends in treatment and outcomes of atrial fibrillation during 2007–17 in Finland 2022 ·European Heart Journal - Quality of Care and Clinical Outcomes ·Konsta Teppo, Juhani Airaksinen, Jussi Jaakkola, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, Juha Hartikainen, Aapo L. Aro, Mika Lehto	21
14	Income and outcomes of patients with incident atrial fibrillation 2022 ·Journal of Epidemiology & Community Health ·Fausto Biancari, Konsta Teppo, Jussi Jaakkola, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, Juha Hartikainen, Aapo L. Aro, Juhani Airaksinen, Mika Lehto	12
15	Rural–Urban differences in Use of Rhythm Control Therapies in Patients with Incident Atrial Fibrillation: A Finnish Nationwide Cohort Study 2022 ·International Journal of Environmental Research and Public Health ·Konsta Teppo, Jussi Jaakkola, Fausto Biancari, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, (unknown), (unknown), Juha Hartikainen, Aapo L. Aro, Juhani Airaksinen, Mika Lehto	3
16	The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study 2021 ·European Heart Journal - Quality of Care and Clinical Outcomes ·Jussi Jaakkola, Konsta Teppo, Fausto Biancari, Olli Halminen, Jukka Putaala, Pirjo Mustonen, Jari Haukka, Miika Linna, Janne Kinnunen, (unknown), Aapo L. Aro, Juha Hartikainen, Juhani Airaksinen, Mika Lehto	24
17	Early Repolarization 2011 ·Circulation ·Jani T. Tikkanen, Juhani Junttila, Olli Anttonen, Aapo L. Aro, (unknown), Tuomas Kerola, Solomon J. Sager, Harri Rissanen, Robert J. Myerburg, Antti Reunanen, Heikki V. Huikuri	268
18	The Childhood Diabetes in Finland Study Group: Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. (vol 49, pg 912, 2000) 2000 ·UCL Discovery (University College London) ·Suvi Μ. Virtanen, (unknown), Elina Hyppönen, Helena Reijonen, L Räsänen, Aapo L. Aro, Mikael Knip, Jorma Ilonen, (unknown)	4
19	Cow's milk consumption, HLA-DQB1 genotype and IDDM: a nested case-control study of siblings of children with diabetes 1999 ·UCL Discovery (University College London) ·Suvi Μ. Virtanen, (unknown), Elina Hyppönen, Helena Reijonen, L Räsänen, Aapo L. Aro, Mikael Knip, Jorma Ilonen, (unknown)	4
20	Chlorpropamide-alcohol flushing and coronary heart disease in non-insulin dependent diabetics. 1983 ·BMJ ·Markku Laakso, Kyösti Nuorva, Aapo L. Aro, Matti Uusitupa, O Siitonen, Risto Huupponen	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact